Dyne Therapeutics Inc. (DYN)
NASDAQ: DYN
· Real-Time Price · USD
12.19
-0.14 (-1.14%)
At close: Aug 19, 2025, 11:50 AM
Dyne Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 3.79M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | 400K | 386K | 567K | 597K | 674K | 623K | 615K | 397K | 1.64M | 1.47M | 341K | 260K | 241K | 231K |
Gross Profit | n/a | n/a | n/a | n/a | -400K | -386K | 3.22M | -597K | -674K | -623K | -615K | -397K | -1.64M | -1.47M | -341K | -260K | -241K | -231K |
Operating Income | -115.79M | -122.37M | -97.11M | -105.66M | -71.96M | -69.16M | -67.69M | -62.27M | -66.74M | -45.46M | -40.15M | -42.28M | -52.76M | -35.78M | -51.96M | -42.77M | -30.16M | -25.13M |
Interest Income | 6.63M | 7.1M | 7.59M | 9.28M | 7.05M | 3M | 1.75M | 2.19M | 2.21M | 1.49M | 1.34M | 903K | 441K | 230K | 182K | 184K | 210K | 166K |
Pretax Income | -110.86M | -115.36M | -89.54M | -97.13M | -65.1M | -65.65M | -66.64M | -60.21M | -64.9M | -44.19M | -38.83M | -41.38M | -52.3M | -35.58M | -51.79M | -42.58M | -29.95M | -24.97M |
Net Income | -110.86M | -115.36M | -89.54M | -97.13M | -65.1M | -65.65M | -66.64M | -60.21M | -64.9M | -42.5M | -37.51M | -40.49M | -52.3M | -35.38M | -51.79M | -42.58M | -29.95M | -24.97M |
Selling & General & Admin | 16.55M | 15.93M | 15.3M | 12.86M | 9.7M | 24.62M | 8.28M | 7.02M | 7.61M | 7.93M | 6.96M | 7.61M | 6.09M | 7.55M | 9.66M | 6.26M | 6.29M | 6.51M |
Research & Development | 99.24M | 106.45M | 81.81M | 92.8M | 62.26M | 44.54M | 58.84M | 55.25M | 59.13M | 37.54M | 33.19M | 34.67M | 46.66M | 28.24M | 42.3M | 36.51M | 23.87M | 18.63M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 506K | n/a | n/a | -373K | 1.28M | 1.32M | -9K | 10K | n/a | 175K | n/a | n/a | n/a |
Operating Expenses | 115.79M | 122.37M | 97.11M | 105.66M | 71.96M | 69.16M | 67.12M | 62.27M | 66.74M | 45.46M | 40.15M | 42.28M | 52.76M | 35.78M | 51.96M | 42.77M | 30.16M | 25.13M |
Interest Expense | -94K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -567K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 122.37M | 97.89M | 105.66M | 71.96M | 69.16M | 67.69M | 62.27M | 66.74M | 45.46M | 40.15M | 42.28M | 52.76M | 35.78M | 51.96M | 42.77M | 30.16M | 25.13M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -431K | n/a | -1.69M | -1.32M | -894K | -441K | -200K | 182K | 184K | 210K | 166K |
Shares Outstanding (Basic) | 113.87M | 109.91M | 101.98M | 100.88M | 92.51M | 81.04M | 61.39M | 61.11M | 59.84M | 56.33M | 52.47M | 51.8M | 51.68M | 51.6M | 51.54M | 51.32M | 51.22M | 49.47M |
Shares Outstanding (Diluted) | 113.87M | 109.91M | 101.98M | 100.88M | 92.51M | 81.04M | 61.39M | 61.11M | 59.84M | 56.33M | 52.47M | 51.8M | 51.68M | 51.6M | 51.54M | 51.32M | 51.22M | 49.47M |
EPS (Basic) | -0.97 | -1.05 | -0.88 | -0.96 | -0.7 | -0.81 | -1.09 | -0.99 | -1.08 | -0.75 | -0.71 | -0.78 | -1.01 | -0.69 | -1 | -0.83 | -0.58 | -0.5 |
EPS (Diluted) | -0.97 | -1.05 | -0.88 | -0.96 | -0.7 | -0.81 | -1.09 | -0.99 | -1.08 | -0.75 | -0.71 | -0.78 | -1.01 | -0.69 | -1 | -0.83 | -0.58 | -0.5 |
EBITDA | -115.79M | -121.87M | -96.66M | -105.22M | -71.96M | -68.77M | -67.29M | -61.84M | -66.31M | -45.05M | -40.15M | -41.88M | -52.3M | -35.36M | -51.45M | -42.51M | -29.92M | -24.9M |
EBIT | n/a | -122.37M | -97.11M | -105.66M | -71.96M | -69.16M | -67.69M | -62.27M | -66.74M | -45.46M | -40.14M | -42.28M | -52.76M | -35.78M | -51.79M | -42.77M | -29.95M | -24.97M |
Depreciation & Amortization | n/a | 502K | 450K | 438K | 399K | 386K | 567K | 597K | 674K | 623K | 615K | 397K | 1.64M | 1.47M | 341K | 260K | 241K | 231K |